Next-Gen heart defibrillators put to the test

NCT ID NCT07360158

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study will test the safety and performance of a new generation of implantable heart devices called CorSky ICDs and CRT-Ds. These devices help control dangerous heart rhythms in people with heart failure or tachyarrhythmia. About 151 participants will be implanted with the device and monitored for 6 months using home monitoring technology.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CorSky ICD or CRT-D device
What this could lead to
If successful, this could confirm that the new CorSky devices are safe and work well for controlling dangerous heart rhythms.
What could go wrong
This is a post-market study, not a large randomized trial. It only follows 151 people for 6 months, so long-term benefits or rare risks may not be fully captured.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fakultní nemocnice u sv. Anny v Brně

    RECRUITING

    Brno, CZ-65691, Czechia

  • Medizinische Universität Graz

    RECRUITING

    Graz, Styria, 8010, Austria

  • Nemocnice Ceske Budejovice, a.s.

    RECRUITING

    České Budějovice, 37001, Czechia

  • SRH Wald-Klinikum Gera GmbH

    RECRUITING

    Gera, Thuringia, 07548, Germany

  • Semmelweis University

    RECRUITING

    Budapest, 1122, Hungary

  • University of Pécs

    RECRUITING

    Pécs, H-7624, Hungary

  • Universitätsklinikum Würzburg

    RECRUITING

    Würzburg, Bavaria, 97080, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.